Suchergebnisse - "Suzuki, Tetsuya"

PubPharm (412)

21

Protocol of Tecopox study : a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox

enthalten in: BMJ open | 2023

von Suzuki, T. | Saito, S. | Tsuzuki, S. | +7

22

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox

enthalten in: Human vaccines & immunotherapeutics | 2023

von Tomita, N. | Terada-Hirashima, J. | Uemura, Y. | +9

23

Early Phase Functional Recovery after Spinal Intramedullary Tumor Resection Could Predict Ambulatory Capacity at 1 Year after Surgery

enthalten in: Asian spine journal | 2023

von Suzuki, T. | Tsuji, O. | Ichikawa, M. | +8

24

Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults : A Single-Arm Study

enthalten in: Life (Basel, Switzerland) | 2023

von Tomita, N. | Morino, E. | Terada-Hirashima, J. | +11

25

Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula

enthalten in: Scientific reports | 2023

von Suzuki, T. | Morioka, S. | Yamamoto, K. | +12

26

Discoloration of fiber-reinforced composite resin disc for computer-aided design/computer-aided manufacturing after immersion in coffee and curry solutions

enthalten in: Dental materials journal | 2023

von Shiozawa, M. | Tsuchida, Y. | Suzuki, T. | +1

27

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis : a multicentre, double-blind, placebo-controlled phase 2b study

enthalten in: Lancet (London, England) | 2023

von Guttman-Yassky, E. | Simpson, E. | Reich, K. | +7

ErratumIn: Lancet. 2023 Jan 21;401(10372):194. - PMID 36549317

28

Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Nomoto, H. | Yamamoto, K. | Isaka, E. | +14

29

Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction

enthalten in: PloS one | 2023

von Yamamoto, K. | Ohsiro, Y. | Suzuki, T. | +10

30

SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response

enthalten in: Microbiology spectrum | 2022

von Takamatsu, Y. | Omata, K. | Shimizu, Y. | +8

UpdateOf: bioRxiv. 2022 Jun 09;:. - PMID 35702154